Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.
Völker LA, Kaufeld J, Balduin G, Merkel L, Kühne L, Eichenauer DA, Osterholt T, Hägele H, Kann M, Grundmann F, Kolbrink B, Schulte K, Gäckler A, Kribben A, Boss K, Potthoff SA, Rump LC, Schmidt T, Mühlfeld AS, Schulmann K, Hermann M, Gaedeke J, Sauerland K, Bramstedt J, Hinkel UP, Miesbach W, Bauer F, Westhoff TH, Bruck H, Buxhofer-Ausch V, Müller TJ, Wendt R, Harth A, Schreiber A, Seelow E, Tölle M, Gohlisch C, Bieringer M, Geuther G, Jabs WJ, Fischereder M, von Bergwelt-Baildon A, Schönermarck U, Knoebl P, Menne J, Brinkkoetter PT; German TTP-Study Group. Völker LA, et al. Among authors: osterholt t. J Thromb Haemost. 2023 Mar;21(3):559-572. doi: 10.1016/j.jtha.2022.11.010. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696206 Free article.
First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy.
Kühne L, Völker LA, Hagmann H, Hägele H, Osterholt T, Eichenauer DA, Thomas A, Breuer J, Grüttner B, Gottschalk I, Kann M, Benzing T, Thevis M, Müller AM, Brinkkoetter PT. Kühne L, et al. Among authors: osterholt t. Br J Haematol. 2022 Feb;196(3):e30-e33. doi: 10.1111/bjh.17833. Epub 2021 Sep 29. Br J Haematol. 2022. PMID: 34585743 No abstract available.
Alternate-day dosing of caplacizumab for immune-mediated thrombotic thrombocytopenic purpura.
Kühne L, Kaufeld J, Völker LA, Wendt R, Schönermarck U, Hägele H, Osterholt T, Eichenauer DA, Bieringer M, von Bergwelt-Baildon A, Fischereder M, Buxhofer-Ausch V, Menne J, Brinkkoetter PT, Knöbl P. Kühne L, et al. Among authors: osterholt t. J Thromb Haemost. 2022 Apr;20(4):951-960. doi: 10.1111/jth.15637. Epub 2022 Jan 23. J Thromb Haemost. 2022. PMID: 35000278 Free article.
Preoperative Short-Term Restriction of Sulfur-Containing Amino Acid Intake for Prevention of Acute Kidney Injury After Cardiac Surgery: A Randomized, Controlled, Double-Blind, Translational Trial.
Osterholt T, Gloistein C, Todorova P, Becker I, Arenskrieger K, Melka R, Koehler FC, Faust M, Wahlers T, Benzing T, Müller RU, Grundmann F, Burst V. Osterholt T, et al. J Am Heart Assoc. 2022 Sep 6;11(17):e025229. doi: 10.1161/JAHA.121.025229. Epub 2022 Sep 3. J Am Heart Assoc. 2022. PMID: 36056721 Free PMC article. Clinical Trial.
A systematic analysis of diet-induced nephroprotection reveals overlapping changes in cysteine catabolism.
Koehler FC, Fu CY, Späth MR, Hoyer-Allo KJR, Bohl K, Göbel H, Lackmann JW, Grundmann F, Osterholt T, Gloistein C, Steiner JD, Antebi A, Benzing T, Schermer B, Schwarz G, Burst V, Müller RU. Koehler FC, et al. Among authors: osterholt t. Transl Res. 2022 Jun;244:32-46. doi: 10.1016/j.trsl.2022.02.003. Epub 2022 Feb 18. Transl Res. 2022. PMID: 35189406
Management of immune thrombotic thrombocytopenic purpura without therapeutic plasma exchange.
Kühne L, Knöbl P, Eller K, Thaler J, Sperr WR, Gleixner K, Osterholt T, Kaufeld J, Menne J, Buxhofer-Ausch V, Mühlfeld A, Seelow E, Schreiber A, Todorova P, Cukoski S, Jabs WJ, Özcan F, Gäckler A, Schönfelder K, Seibert FS, Westhoff T, Schwenger V, Eichenauer DA, Völker LA, Brinkkoetter PT. Kühne L, et al. Among authors: osterholt t. Blood. 2024 Oct 3;144(14):1486-1495. doi: 10.1182/blood.2023023780. Blood. 2024. PMID: 38838300
Electrophysiological Characterization of a MYH7 Variant with Tremor Phenotype.
Vial F, McGurrin P, Osterholt T, Ehrlich DJ, Iannacone ST, Donkervoort S, Neuhaus SB, Chao KC, Bönnemann CG, Haubenberger D, Hallett M. Vial F, et al. Among authors: osterholt t. Mov Disord Clin Pract. 2023 Mar 14;10(4):646-651. doi: 10.1002/mdc3.13664. eCollection 2023 Apr. Mov Disord Clin Pract. 2023. PMID: 37070061 Free PMC article.
[Nephrotic syndrome: Current understanding and future therapies].
Diefenhardt P, Osterholt T, Brinkkötter P. Diefenhardt P, et al. Among authors: osterholt t. Dtsch Med Wochenschr. 2022 Mar;147(6):332-336. doi: 10.1055/a-1334-2135. Epub 2022 Mar 15. Dtsch Med Wochenschr. 2022. PMID: 35291039 German.
17 results